The Third Vaccine, and Vaccine Choice

a16z’s Alex Rampell and Joe Schmidt sit down with Lightfield co-founder and CEO Keith Peiris to discuss what it takes to rethink the CRM for an AI-native world, and the unusual pivot that got him there.Keith previously built Tome to 25 million users, but eventually walked away fr ...  Show more

This interview with Stripe cofounders John and Patrick Collison originally aired on TBPN. They discuss Stripe's 34% growth and new employee tender offer, how agent commerce and stablecoins may require high-throughput blockchains built for millions of transactions per second, and ...  Show more

The Johnson & Johnson vaccine for COVID-19 is a one-dose viral vector vaccine that's about as effective as the mRNA vaccines available. Learn how it works in this episode of BrainStuff. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/lis ...  Show more

Several vaccine companies have announced promising early evidence that their vaccines are effective at preventing symptoms of a coronavirus infection. So what comes next? CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to vaccine creator and virology and immunology expert, ...  Show more

Dr. Dan Barouch is the director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston, and is helping develop Johnson & Johnson’s vaccine candidate. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to him about how this vaccine is ...  Show more

Skip Montreux and Samantha Vega report on recent developments in the race to develop a vaccine for COVID-19. Audio script available at downtobusinessenglish.com Visit Apple Podcasts to subscribe to Down to Business English, rate the show, and leave a comment. Visit our website or ...  Show more